The fight against tuberculosis (TB) could soon get sharper. Researchers at the Hyderabad-based Centre for DNA Fingerprinting and Diagnostics (CDFD) have got new insight into the molecular mechanism of the TB bacterium that helps it evade the human immune system.

The Indian Council of Medical Research (ICMR) on July 15, 2019 said it has launched the third-phase trials for an anti-Tuberculosis vaccine that could be administered to anybody aged six years and above. Current BCG vaccines is only for neonates.